Across TCGA pan-cancer cohorts, DNAJC19P6 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated DNAJC19P6 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher DNAJC19P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DNAJC19P6 expression acts as an unfavorable survival marker, although some lineages such as OV and LUAD show a favorable association.
SKCM, LIHC, and PCPG are the cancer types where DNAJC19P6 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.